Capitalizator.

Capitalize Yourself: Right Data. Real Growth.

Company Analysis

AH Insider Trading

AH | Market Equity

Comprehensive Trading Performance Summary

The investment history of corporate insiders at AH provides a unique lens into the internal conviction of the company's leadership. By analyzing SEC Form 4 filings, investors can track how directors and officers are allocating their own capital. High-conviction buying often signals that management believes the current market price significantly undervalues future growth prospects, while strategic selling might occur for personal liquidity or portfolio diversification. Monitoring these shifts in ownership is essential for understanding the alignment between management and shareholders in the Market Equity sector.

Last 7 Days
$0
Buys
$0
Sells
Last 30 Days Trend
$0
Buys
$0
Sells

Transactions on Chart

Open Full Chart
Filing Date Trade Date Reporting Person Relationship Type Price Qty Total, $ Owned After Change, %
2012-11-30 01:05 2012-11-27 BRONFMAN EDGAR JR Director SELL $11.28 125,000 $1,410,363 138,783 -47.4%
2012-09-15 00:06 2012-09-12 BRONFMAN EDGAR JR Director SELL $12.32 250,000 $3,080,300 263,783 -48.7%
2011-08-19 01:02 2011-08-16 Spiegel Arthur H. III Director SELL $28.63 141,931 $4,063,243 3,576,936 -3.8%
2011-04-01 17:21 2011-03-30 Spiegel Arthur H. III Director SELL $22.44 198,842 $4,462,512 3,718,867 -5.1%
2011-04-01 17:20 2011-03-30 TOLAN MARY A Director, Officer, 10% owner - Founder, President and CEO SELL $22.44 750,000 $16,831,875 9,329,988 -7.4%
2011-04-01 17:19 2011-03-30 Kazarian Gregory N. Officer - Senior Vice President SELL $22.44 75,000 $1,683,188 100,218 -42.8%
2011-04-01 17:18 2011-03-30 Staton John T. Officer - CFO and Treasurer SELL $22.44 82,175 $1,844,212 0 -100.0%
2011-04-01 17:17 2011-03-30 Deffarges Etienne H. Officer - Executive VP SELL $22.44 540,000 $12,118,950 4,723,878 -10.3%
2011-04-01 00:30 2011-03-30 FW Oak Hill Accretive Healthcare Investors, L.P. 10% owner SELL $22.44 814,110 $18,268,628 14,036,172 -5.5%
2011-03-30 22:10 2011-03-30 ACCRETIVE INVESTORS SBIC LP 10% owner SELL $22.44 1,956,321 $43,899,843 18,560,545 -9.5%
2010-05-27 22:27 2010-05-25 SHULTZ GEORGE P Director SELL $11.28 33,844 $381,760 677,120 -4.8%
2010-05-27 22:26 2010-05-25 TOLAN MARY A Director, Officer, 10% owner - Founder, President and CEO SELL $11.28 719,026 $8,110,613 9,975,389 -6.7%
2010-05-27 22:25 2010-05-25 Staton John T. Officer - CFO and Treasurer SELL $11.28 74,659 $842,154 82,175 -47.6%
2010-05-27 22:25 2010-05-25 Spiegel Arthur H. III Director SELL $11.28 196,320 $2,214,490 3,875,483 -4.8%
2010-05-27 22:24 2010-05-25 Kazarian Gregory N. Officer - Senior Vice President SELL $11.28 68,183 $769,104 67,482 -50.3%
2010-05-27 22:24 2010-05-25 Kaplan Steven N Director SELL $11.28 19,425 $219,114 388,641 -4.8%
2010-05-27 22:23 2010-05-25 Deffarges Etienne H. Officer - Executive VP SELL $11.28 288,578 $3,255,160 5,263,878 -5.2%
2010-05-27 22:23 2010-05-25 CLINE J MICHAEL Director, 10% owner SELL $11.28 995,348 $11,227,525 19,913,648 -4.8%
2010-05-27 22:22 2010-05-25 Bolotin James M. Officer - Corporate Controller BUY $12.00 1,000 $12,000 1,000 +100.0%
2010-05-27 22:22 2010-05-25 Ascension Health 10% owner SELL $11.28 393,415 $4,437,721 7,674,087 -4.9%
2010-05-27 21:07 2010-05-25 Accretive Associates SBIC, LLC 10% owner SELL $11.28 995,348 $11,227,525 19,913,648 -4.8%
2005-12-02 02:18 2005-11-29 KANDERS WARREN B Director, Officer - Chairman of the Board and CEO OPT+S $44.01 366,057 $16,108,814 157,964 0.0%
2005-12-02 02:18 2005-11-29 EHRLICH BURTT R Director SELL $44.02 37,500 $1,650,750 51,380 -42.2%
2005-08-20 01:24 2005-08-17 SCHILLER ROBERT Director, Officer - President and COO OPT+S $42.40 230,000 $9,752,874 184,902 0.0%
2005-08-20 01:23 2005-08-17 HEIAR GLENN J Officer - Chief Financial Officer OPT+S $42.42 66,901 $2,837,853 34,265 0.0%
2005-08-20 01:23 2005-08-17 STRAUSS THOMAS W Director OPT+S $42.40 25,000 $1,060,095 12,500 0.0%
2005-05-24 02:41 2005-05-19 SOKOLOW NICOLAS Director OPT+S $35.82 9,000 $322,360 25,591 0.0%
2005-03-02 03:22 2005-02-28 SOKOLOW NICOLAS Director OPT+S $40.14 12,000 $481,638 15,591 0.0%
2004-11-19 05:52 2004-11-16 KANDERS WARREN B Director, Officer - Chairman of the Board and CEO OPT+S $41.95 204,375 $8,572,755 0 0.0%
2004-11-19 05:48 2004-11-16 SCHILLER ROBERT Officer - President and COO OPT+S $41.95 204,374 $8,572,713 0 0.0%
2004-11-19 05:44 2004-11-16 SOKOLOW NICOLAS Director OPT+S $41.95 28,409 $1,191,650 11,200 0.0%
2004-11-19 05:43 2004-11-16 STRAUSS THOMAS W Director OPT+S $41.95 28,409 $1,191,650 12,500 0.0%
2004-11-19 05:41 2004-11-16 CROSKREY STEPHEN Officer - President and CEO--Prod. Div. OPT+S $41.95 110,000 $4,614,082 152,945 0.0%
2004-11-19 05:38 2004-11-16 EHRLICH BURTT R Director OPT+S $41.95 28,409 $1,191,650 83,000 0.0%
2004-11-19 05:32 2004-11-16 HEIAR GLENN J Officer - Chief Financial Officer OPT+S $41.95 31,818 $1,334,644 16,520 0.0%
2004-11-19 05:28 2004-11-16 MECREDY ROBERT F Officer - President-Aerospace & Def Grp OPT+S $41.95 50,000 $2,097,310 7,312 0.0%
2004-11-19 05:28 2004-11-16 ZOULLAS DEBORAH A Director OPT+S $41.95 14,206 $595,888 0 0.0%
SHOW ENTRIES
1-37 OF 37

How to Interpret $AH Trades

Not every insider transaction in AH is a signal for immediate action. Professional investors look for "cluster buying"—when multiple executives simultaneously purchase $AH shares on the open market. It is crucial to distinguish between scheduled sales (under Rule 10b5-1) and voluntary increases in ownership, which demonstrate management’s true conviction that the stock is undervalued.

Data Source & Accuracy for AH

Insider activity data for AH is streamed in real-time directly from the SEC EDGAR system. We analyze raw Form 4 filings, filtering out technical adjustments and complex derivative transactions. This provides a transparent view of how ownership structure is evolving in $AH, allowing you to follow the capital of those with the most intimate knowledge of the company.

UNDERSTANDING THE DATA

FILING DATE: The date and time when the transaction was reported to the SEC. This is when the public first receives the information.

TRADE DATE: The actual day the insider executed the purchase or sale in the market.

INDUSTRY: The specific market sector the company operates in. Useful for identifying broader institutional capital flows across sectors.

OWNED AFTER: The total number of shares held by the insider following the transaction. This highlights the insider's remaining conviction in the company.

CHANGE %: The percentage increase or decrease of the insider's total position. Large percentage changes often carry more weight than the dollar amount alone.

TRADE TYPES DEFINITIONS

BUY: An open market purchase. Typically indicates an insider's belief that the stock is undervalued or poised for growth.

SELL: An open market sale. While often used for diversification or liquidity, large or unexpected sales can be a warning signal.

OPT+S (OPTION EXERCISE & SALE): This occurs when an insider exercises their stock options and sells them immediately. Often part of a structured compensation plan.